当前位置：首页 > 文献互助 > 互助详情

Targeting IRAK4 kinase in autoimmune diseases and cancer复制

用户b8hUGnyUFz-o 1个月前 88 10 已完结

1. 系统已在2025-09-05 14:28:17对应助文件进行删除

2. 如有需要请重新发布求助信息

注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规

DOI:复制

文献链接:复制

其他信息:

A Synáčková
2022
dspace.cuni.cz
… As a fundamental molecule in IL-1R/TLR signaling, IRAK4 alterations are often the cause of IL-R/TLR-mediated autoimmunities. The involvement of these receptor pathways in …

上一篇：A novel inhalable nanobody targeting IL-4Rα for the treatment of asthma

下一篇：Basic Stability Tests of Machine Learning Potentials for Molecular Simulations in Computational Drug Discovery

互助时间线

2025-09-03 13:23:00 [完结求助]

系统完结了求助, 已自动确认了jodie0105应助的文件是正确的, 求助状态变成 已完结

2025-08-29 14:28:17 [上传文件]

jodie0105上传了文件(pdf 1.71 MB), 求助状态变成 待确认

2025-08-29 13:23:00 [发起求助]

最新发布的求助

Natural products targeting the PI3K-Akt-mTOR signaling pathway in cancer: A novel therapeutic strategy 25分钟前
Multi-omics identifies key genetic and metabolic networks regulating spike organ development in wheat 1小时前
Human pancreatic α-cell heterogeneity and trajectory inference analyses reveal SMOC1 as a β-cell dedifferentiation gene 1小时前
Improving outcomes of patients with pancreatic cancer 1小时前
Serum Myeloperoxidase, Uric Acid, and the Risk of Atrial Fibrillation in Chronic Kidney Disease 1小时前
Selective carbon dioxide electroreduction to ethylene and ethanol by core-shell copper/cuprous oxide 1小时前
Pyridazine: A privileged scaffold in the development of 21st-century pesticides 1小时前
Detection and Management of Tracheal Stenosis Following Cuffed Tube Tracheostomy 1小时前
Ivonescimab in advanced NSCLC: is progression-free survival enough, or are overall survival data also needed? 1小时前
Al-Doped Octahedral Cu2O Nanocrystal for Electrocatalytic CO2 Reduction to Produce Ethylene 1小时前
Augmenting clinical trials in asthma through digital technology, decentralised designs, and person-centric endpoints: opportunities and challenges 2小时前
Outils connectés pour la télésurveillance des patients asthmatiques : gadgets ou révolution? 2小时前

wispass工作室 Copyright © 蜀ICP备2024051606号-2 www.wispass.com